| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | NG-25 | GDSC1000 | pan-cancer | AAC | -0.042 | 0.2 |
| mRNA | BRD9876 | CTRPv2 | pan-cancer | AAC | -0.052 | 0.2 |
| mRNA | BIX02189 | GDSC1000 | pan-cancer | AAC | -0.044 | 0.2 |
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | -0.061 | 0.2 |
| mRNA | temsirolimus | CTRPv2 | pan-cancer | AAC | 0.065 | 0.2 |
| mRNA | TAE684 | CTRPv2 | pan-cancer | AAC | -0.048 | 0.2 |
| mRNA | navitoclax:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.049 | 0.2 |
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | -0.043 | 0.2 |
| mRNA | lapatinib | FIMM | pan-cancer | AAC | 0.26 | 0.2 |
| mRNA | Carboplatin | CTRPv2 | pan-cancer | AAC | 0.049 | 0.2 |